04/26/2024
4:26 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form S-1/A | |
04/26/2024
3:13 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:43 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:59 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K/A | |
02/13/2024
7:24 AM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
3:30 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:09 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
01/29/2024
3:30 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:01 AM | AMERICAN FINANCIAL GROUP INC (Filed by)
Onconetix, Inc. (Subject)
Onconetix (Subject)
| Form SC 13G/A | |
01/19/2024
3:05 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:51 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
12:13 PM | Onconetix, Inc. (Subject)
Onconetix (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/28/2023
3:53 PM | Bruhlmann Christian (Reporting)
Onconetix, Inc. (Issuer)
Onconetix (Issuer)
Onconetix, Inc. (Issuer)
Onconetix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2023
5:34 PM | Altos Venture AG (Filed by)
Onconetix, Inc. (Subject)
Onconetix (Subject)
| Form SC 13G | |
12/27/2023
3:51 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K/A | |
12/21/2023
3:56 PM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
7:00 AM | Onconetix, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:11 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
4:23 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2023
6:38 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form NT 10-Q | |
11/01/2023
7:15 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
8:58 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
4:12 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023
4:00 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:48 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Harmon Bruce (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
5:49 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
CAMPBELL NEIL J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
8:08 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
7:01 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
3:41 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
3:30 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
4:27 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
4:22 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form NT 10-Q | |
08/10/2023
8:15 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
1:29 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
7:25 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
8:00 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2023
8:55 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
8:05 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
8:06 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
4:00 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
4:11 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
07/06/2023
6:40 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
9:34 AM | Blue Water Biotech, Inc. (Subject)
Onconetix (Subject)
Cincinnati Cornerstone Investors BWV I, LLC (Filed by)
| Form SC 13D | |
06/28/2023
7:00 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
6:30 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:03 AM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
3:40 PM | Blue Water Biotech, Inc. (Filer)
Onconetix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
8:10 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
SAPIRSTEIN JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:10 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Tarsh Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:11 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Ramdeen Timothy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
8:11 PM | Blue Water Biotech, Inc. (Issuer)
Onconetix (Issuer)
Jeremic Vuk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
